[{"id":6088,"regimens":[{"id":11483,"duration":{"id":5538,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7165,"name":"Darunavir","url":"cure-api2.ncats.io/v1/drugs/7165","rxNorm_id":null,"notes":null},"use_drug":[{"id":8100,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11483},{"id":8101,"answer":"In a novel combination with another drug","answer_other":"","regimen":11483}],"created":"2020-09-24T17:47:39.762480Z","updated":"2020-12-17T20:13:53.761893Z","dose":"600 mg","frequency":"BD","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11484,"duration":{"id":5539,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10164,"name":"Ritonavir","url":"cure-api2.ncats.io/v1/drugs/10164","rxNorm_id":null,"notes":null},"use_drug":[{"id":8169,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11484},{"id":8170,"answer":"In a novel combination with another drug","answer_other":"","regimen":11484}],"created":"2020-09-24T17:47:39.770463Z","updated":"2020-12-17T20:13:53.768445Z","dose":"100 mg","frequency":"BD","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11485,"duration":{"id":5540,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":8171,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11485},{"id":8172,"answer":"In a novel combination with another drug","answer_other":"","regimen":11485}],"created":"2020-09-24T17:47:39.776501Z","updated":"2020-12-17T20:13:53.773934Z","dose":"400 mg","frequency":"OD","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11486,"duration":{"id":5541,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11165,"name":"Favipiravir","url":"cure-api2.ncats.io/v1/drugs/11165","rxNorm_id":null,"notes":null},"use_drug":[{"id":8173,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11486},{"id":8174,"answer":"In a novel combination with another drug","answer_other":"","regimen":11486}],"created":"2020-09-24T17:47:39.782617Z","updated":"2020-12-17T20:13:53.779733Z","dose":"loading dose of 1600 mg orally every 12 h, followed by 600 mg orally every 8 h","frequency":"TDS","route":"PO","severity":"ICU/Critical Care","severity_detail":"","comments":null,"report":6088},{"id":11487,"duration":{"id":5542,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9593,"name":"Peginterferon Alfa-2A","url":"cure-api2.ncats.io/v1/drugs/9593","rxNorm_id":null,"notes":null},"use_drug":[{"id":8175,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":11487},{"id":8176,"answer":"In a novel combination with another drug","answer_other":"","regimen":11487}],"created":"2020-09-24T17:47:39.788562Z","updated":"2020-12-17T20:13:53.811309Z","dose":"180 μg","frequency":"single dose","route":"subcutaneously","severity":"ICU/Critical Care","severity_detail":null,"comments":null,"report":6088}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8023,"answer":"Imaging","answer_other":"","report":6088},{"id":8024,"answer":"PCR","answer_other":"","report":6088},{"id":8025,"answer":"Clinical assessment","answer_other":"","report":6088}],"how_diagnosis":[{"id":13602,"answer":"Clinical assessment","answer_other":"","report":6088},{"id":13603,"answer":"Imaging","answer_other":"","report":6088},{"id":13604,"answer":"PCR","answer_other":"","report":6088}],"author_username":"Parvesh Paul","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Medical Doctor","author_affiliation":"Christian Medical College, Ludhiana, Punjab, India.","author_country":"India","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4079,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6088},{"id":4080,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6088}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"},{"id":550,"name":"Respiratory Tract Infections"}],"races":[{"id":336,"answer":"White","answer_other":""}],"created":"2020-09-24T17:44:37.657208Z","updated":"2020-12-17T20:13:53.754280Z","title":"Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a. Case 1","status":"Approved","anonymous":false,"published":true,"pubmed_id":32483527,"doi":"10.1016/j.idcr.2020.e00837","article_url":"https://pubmed.ncbi.nlm.nih.gov/32483527/","pub_year":2020,"published_authors":"El-Lababidi RM\r\nMooty M\r\nBonilla MF\r\nSalem NM","article_author_email":"Author email could not be found.","journal":"IDCases","abstract":"The outbreak of the new coronavirus disease 2019 (COVID-19) has spread rapidly worldwide. Until now, no definite effective treatment has been identified. We reported 3 patients with severe COVID-19 treated with pegylated interferon alfa 2a with satisfactory recovery. Based on these observations, randomized studies with interferons should be considered in deteriorating patients infected with COVID-19.          \r\n        Keywords:      \r\n                  Coronavirus disease 2019; Interferons; Pegylated interferon alfa 2a; SARS-CoV-2.","article_type":"Original","study_type":"Case Report","number_of_patients":3,"article_patient_number":"1","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":"Not Hispanic/Latino","country_contracted":"Italy","country_treated":"United Arab Emirates","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"A sputum culture with gram stain as well as methicillin-resistant S. aureus nasal swab were collected, and an empiric antibacterial regimen of cefepime and intravenous vancomycin was initiated to cover a possible hospital-acquired pneumonia.\r\nCefepime and vancomycin were de-escalated to amoxicillin-clavulanate when sputum culture showed growth of normal oral flora and the MRSA nasal swab was negative.\r\nFavipiravir was added to his regimen at a loading dose of 1600 mg orally every 12 h, followed by 600 mg orally every 8 h, and hydroxychloroquine was discontinued.","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7165,11165,8342,9593,10164]},{"id":6662,"regimens":[{"id":13324,"duration":{"id":7213,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8971,"name":"Meropenem","url":"cure-api2.ncats.io/v1/drugs/8971","rxNorm_id":null,"notes":null},"use_drug":[{"id":11817,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13324},{"id":11818,"answer":"In a novel combination with another drug","answer_other":"","regimen":13324}],"created":"2020-12-02T22:19:43.350868Z","updated":"2020-12-17T20:40:43.881632Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation","comments":null,"report":6662},{"id":13325,"duration":{"id":7214,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8745,"name":"Linezolid","url":"cure-api2.ncats.io/v1/drugs/8745","rxNorm_id":null,"notes":null},"use_drug":[{"id":11819,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13325},{"id":11820,"answer":"In a novel combination with another drug","answer_other":"","regimen":13325}],"created":"2020-12-02T22:19:43.358998Z","updated":"2020-12-17T20:40:43.887847Z","dose":"","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation","comments":null,"report":6662},{"id":13326,"duration":{"id":7215,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11218,"name":"Trimethoprim Sulfamethoxazole","url":"cure-api2.ncats.io/v1/drugs/11218","rxNorm_id":null,"notes":null},"use_drug":[{"id":11821,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13326},{"id":11822,"answer":"In a novel combination with another drug","answer_other":"","regimen":13326}],"created":"2020-12-02T22:19:43.365215Z","updated":"2020-12-17T20:40:43.893354Z","dose":"20mg per kg body weight","frequency":"q4d","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation","comments":null,"report":6662},{"id":13327,"duration":{"id":7216,"approximate_duration":null,"dates_unknown":false},"drug":{"id":9912,"name":"Prednisone","url":"cure-api2.ncats.io/v1/drugs/9912","rxNorm_id":null,"notes":null},"use_drug":[{"id":11823,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13327},{"id":11824,"answer":"In a novel combination with another drug","answer_other":"","regimen":13327}],"created":"2020-12-02T22:19:43.372140Z","updated":"2020-12-17T20:40:43.899044Z","dose":"50mg","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation","comments":null,"report":6662},{"id":13328,"duration":{"id":7217,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7165,"name":"Darunavir","url":"cure-api2.ncats.io/v1/drugs/7165","rxNorm_id":null,"notes":null},"use_drug":[{"id":11825,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13328},{"id":11826,"answer":"In a novel combination with another drug","answer_other":"","regimen":13328}],"created":"2020-12-02T22:19:43.378648Z","updated":"2020-12-17T20:40:43.904539Z","dose":"600mg","frequency":"BID","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation","comments":null,"report":6662},{"id":13329,"duration":{"id":7218,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11251,"name":"Emtricitabine-Tenofovir Disoproxil Fumarate","url":"cure-api2.ncats.io/v1/drugs/11251","rxNorm_id":null,"notes":null},"use_drug":[{"id":11827,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13329},{"id":11828,"answer":"In a novel combination with another drug","answer_other":"","regimen":13329}],"created":"2020-12-02T22:19:43.384939Z","updated":"2020-12-17T20:40:43.945780Z","dose":"450/400mg","frequency":"QD","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation","comments":null,"report":6662},{"id":13330,"duration":{"id":7219,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8073,"name":"Ganciclovir","url":"cure-api2.ncats.io/v1/drugs/8073","rxNorm_id":null,"notes":null},"use_drug":[{"id":11829,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13330},{"id":11830,"answer":"In a novel combination with another drug","answer_other":"","regimen":13330}],"created":"2020-12-02T22:19:43.391480Z","updated":"2020-12-17T20:40:43.916439Z","dose":"5mg/kg body weight","frequency":"","route":"","severity":"ICU/Critical Care","severity_detail":"Intubation and mechanical ventilation","comments":null,"report":6662}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8742,"answer":"Clinical assessment","answer_other":"","report":6662},{"id":8743,"answer":"PCR","answer_other":"","report":6662}],"how_diagnosis":[{"id":15029,"answer":"Clinical assessment","answer_other":"","report":6662},{"id":15030,"answer":"Imaging","answer_other":"","report":6662},{"id":15031,"answer":"PCR","answer_other":"","report":6662}],"author_username":"Paige Evans","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":4849,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6662},{"id":4850,"answer":"Co-Infection or Complex Co-morbidities","answer_other":"","report":6662}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":540,"name":"Pneumocystis Jiroveci Pneumonia (Pcp)"}],"races":[],"created":"2020-12-02T22:15:46.539198Z","updated":"2020-12-17T20:40:43.873607Z","title":"Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32607564,"doi":"10.1093/cid/ciaa906","article_url":"https://pubmed.ncbi.nlm.nih.gov/32607564/","pub_year":2020,"published_authors":"Mang S\r\nKaddu-Mulindwa D\r\nMetz C\r\nBecker A\r\nSeiler F\r\nSmola S\r\nMaßmann A\r\nBecker SL\r\nPapan C\r\nBals R\r\nLepper PM\r\nDanziger G","article_author_email":"sebastian.mang@uks.eu","journal":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","abstract":"We report the case of a 50-some-old man from our intensive care unit (ICU) who developed acute respiratory failure due to COVID- 19, Pneumocystis jirovecii pneumonia (PJP), and newly diagnosed stage 3 HIV [2]. Diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disguised the presence of PJP.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"51-60 years","sex":"Male","ethnicity":null,"country_contracted":"Germany","country_treated":"Germany","began_treatment_year":"2020","hiv":true,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Acute respiratory failure, Pneumocystis jirovecii pneumonia","severity":null,"prev_treatment":"","unusual":"Patient with newly diagnosed HIV-1 contracts COVID-19.","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"At the time the treatment was completed","follow_up_period":null,"relapse":"Unknown","reminder":false,"when_reminder":"1 week","additional_info":"The case is remarkable for several reasons: \r\n(1) SARS-CoV-2 infection initially prompted physicians to neglect other causes of respiratory failure; \r\n(2) the patient was immunosuppressed by HIV, which might have caused a mild course of\r\nCOVID-19; and \r\n(3) administration of ART to analgosedated patients on the ICU is challenging since most currently approved therapeutics are pills that cannot be pulverized","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[7165,11251,8073,8745,8971,9912,11218]},{"id":6826,"regimens":[{"id":13847,"duration":{"id":7739,"approximate_duration":null,"dates_unknown":false},"drug":{"id":7165,"name":"Darunavir","url":"cure-api2.ncats.io/v1/drugs/7165","rxNorm_id":null,"notes":null},"use_drug":[{"id":12816,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13847},{"id":12817,"answer":"In a novel combination with another drug","answer_other":"","regimen":13847}],"created":"2020-12-29T19:56:00.169570Z","updated":"2020-12-29T20:02:17.092564Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13848,"duration":{"id":7740,"approximate_duration":null,"dates_unknown":false},"drug":{"id":10164,"name":"Ritonavir","url":"cure-api2.ncats.io/v1/drugs/10164","rxNorm_id":null,"notes":null},"use_drug":[{"id":12818,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13848},{"id":12819,"answer":"In a novel combination with another drug","answer_other":"","regimen":13848}],"created":"2020-12-29T19:56:00.177380Z","updated":"2020-12-29T20:02:17.099201Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13849,"duration":{"id":7741,"approximate_duration":null,"dates_unknown":false},"drug":{"id":11165,"name":"Favipiravir","url":"cure-api2.ncats.io/v1/drugs/11165","rxNorm_id":null,"notes":null},"use_drug":[{"id":12820,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13849},{"id":12821,"answer":"In a novel combination with another drug","answer_other":"","regimen":13849}],"created":"2020-12-29T19:56:00.183628Z","updated":"2020-12-29T20:02:17.104679Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13850,"duration":{"id":7742,"approximate_duration":null,"dates_unknown":false},"drug":{"id":8342,"name":"Hydroxychloroquine","url":"cure-api2.ncats.io/v1/drugs/8342","rxNorm_id":null,"notes":null},"use_drug":[{"id":12822,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13850},{"id":12823,"answer":"In a novel combination with another drug","answer_other":"","regimen":13850}],"created":"2020-12-29T19:56:00.190387Z","updated":"2020-12-29T20:02:17.110610Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13851,"duration":{"id":7743,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6122,"name":"Azithromycin","url":"cure-api2.ncats.io/v1/drugs/6122","rxNorm_id":null,"notes":null},"use_drug":[{"id":12824,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13851},{"id":12825,"answer":"In a novel combination with another drug","answer_other":"","regimen":13851}],"created":"2020-12-29T19:56:00.196543Z","updated":"2020-12-29T20:02:17.116258Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826},{"id":13852,"duration":{"id":7744,"approximate_duration":null,"dates_unknown":false},"drug":{"id":6675,"name":"Ceftriaxone","url":"cure-api2.ncats.io/v1/drugs/6675","rxNorm_id":null,"notes":null},"use_drug":[{"id":12826,"answer":"To treat a disease other than the one for which the drug is approved","answer_other":"","regimen":13852},{"id":12827,"answer":"In a novel combination with another drug","answer_other":"","regimen":13852}],"created":"2020-12-29T19:56:00.202785Z","updated":"2020-12-29T20:02:17.122076Z","dose":"","frequency":"","route":"","severity":"Inpatient","severity_detail":"","comments":null,"report":6826}],"site_of_infection":[],"specific_site":[],"how_outcome":[{"id":8975,"answer":"Clinical assessment","answer_other":"","report":6826},{"id":8976,"answer":"Imaging","answer_other":"","report":6826}],"how_diagnosis":[{"id":15435,"answer":"Clinical assessment","answer_other":"","report":6826},{"id":15436,"answer":"Imaging","answer_other":"","report":6826},{"id":15437,"answer":"PCR","answer_other":"","report":6826}],"author_username":"Kate Borkowski","resistant_drugs":[],"combo_drugs":[],"organisms":[{"id":1887,"name":"Severe acute respiratory syndrome coronavirus 2 (sars-cov-2)"}],"disease_name":"COVID-19","author_qualification":"Nurse","author_affiliation":"None","author_country":"","outcome_computed":"Improved","previous_drugs":[],"comments":[],"article_language":"English","why_new_way":[{"id":5066,"answer":"There is no standard/approved therapy for this disease","answer_other":"","report":6826}],"adverse_event_outcome":[],"is_author":false,"cross_linked_diseases":[{"id":396,"name":"Pneumonia"}],"races":[],"created":"2020-12-29T19:54:57.199710Z","updated":"2020-12-29T20:02:17.084410Z","title":"'Ring of fire' appearance in COVID-19 pneumonia.","status":"Approved","anonymous":false,"published":true,"pubmed_id":32587120,"doi":"10.1136/bcr-2020-236167","article_url":"https://pubmed.ncbi.nlm.nih.gov/32587120/","pub_year":2020,"published_authors":"Piyavisetpat N\r\nPongpirul K\r\nSukkasem W\r\nPantongrag-Brown L","article_author_email":"doctorkrit@gmail.com","journal":"BMJ case reports","abstract":"Since the beginning of the outbreak in December 2019, many radiologic findings in COVID-19 pneumonia have been described in the literature. The predominant lung finding is ground-glass opacities, some with a round morphology. A crazy-paving pattern, consolidation with or without a peripheral halo, air bronchograms, thickened interlobular septa and adjacent pleura are also reported. The abnormalities have a predilection for the peripheral and subpleural regions of the lungs and are commonly bilateral. A peribronchovascular distribution has not been common in the reports of COVID-19 pneumonia.","article_type":"Original","study_type":"Case Report","number_of_patients":1,"article_patient_number":"","full_text_available":true,"outcome":"Patient was cured/recovered","surgery":"No","age":"31-40 years","sex":"Male","ethnicity":null,"country_contracted":"Thailand","country_treated":"Thailand","began_treatment_year":"2020","hiv":false,"asthma":false,"lung_disease":false,"diabetes_mellitus":false,"hypertension":false,"cardiovascular_disease":false,"chronic_renal_disease":false,"chronic_liver_disease":false,"immunosuppressant_drugs":false,"intellectual_disability":false,"smoker":false,"other_immunodeficiency":false,"other_comorbid":"","pregnant":false,"unknown":false,"site_of_disease":"Lungs","clinical_syndrome":"Pneumonia","severity":null,"prev_treatment":"","unusual":"Chest CT performed on the seventh day of his illness revealed a ring-like opacity in the apicoposterior segment of the left upper lobe. This ring-like abnormality was a mixture of consolidation and ground-glass opacity along with the peribronchovascular bundle with wavy contour, mimicking a flame.","drug_treatment_features":"","have_adverse_events":false,"adverse_events":"","when_outcome":"After a period of follow-up","follow_up_period":"1 week after start of treatment","relapse":"No","reminder":false,"when_reminder":"1 week","additional_info":"","previously_treated":"","flagged":false,"other_coinfections":"","disease":630,"drugs":[6122,6675,7165,11165,8342,10164]}]